Stealth BioTherapeutics Corp MITO

Full chart Compare
Set alert

Price alert · MITO

All alert types
0.32 0.00 (+0.00%)

At closeNov 15, 2022, 4:00 PM EST

0.32 Day range 0.33

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $21.09MGross Profit → Expenses: $21.09MExpenses → Selling, General & Admin: $22.32MExpenses → Research & Development: $44.60MExpenses → Interest Expense: $6.67MExpenses → Other Expenses: $19.23MNet Loss → Expenses: $71.73MGross Profit$21.09MNet Loss$71.73MExpenses$92.81MSelling, General & Admin$22.32MResearch & Development$44.60MInterest Expense$6.67MOther Expenses$19.23MRevenue$21.09M

Latest period ending Dec 31, 2021 · select a line to chart its full history

MITO annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-46.30M-48.67M-45.83M-75.28M-79.72M
-52.53M-57.46M-71.73M-96.71M-82.91M
-0.96-1.20-2.28-16.92-14.52
MITO annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
47.13M32.79M50.77M10.86M4.12M
50.23M35.85M52.74M15.52M7.15M
95.52M46.22M35.48M190.85M87.06M
13.66M9.00M16.24M122.04M64.05M
-45.30M-10.37M17.27M-386.71M-291.29M
MITO annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-44.97M-53.54M-47.98M-72.08M-69.83M
183.00K-60.00K-130.00K-12.00K-173.00K
59.14M35.62M88.03M78.83M64.42M
-67.00K-35.00K-130.00K-12.00K-161.00K
14.35M-17.98M39.91M6.74M-5.59M